Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)
China
· Delayed Price · Currency is CNY 8.82
+0.07 (0.80%)
Jun 6, 2025, 2:45 PM CST
SHE:002728 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 4,405 | 4,457 | 6,511 | 4,998 | 3,794 | 2,420 | Upgrade
|
| Market Cap Growth | -31.60% | -31.55% | 30.26% | 31.73% | 56.81% | -29.48% | Upgrade
|
| Enterprise Value | 4,385 | 4,497 | 6,483 | 5,397 | 4,334 | 2,944 | Upgrade
|
| Last Close Price | 8.80 | 8.95 | 12.35 | 10.82 | 7.82 | 5.22 | Upgrade
|
| PE Ratio | 108.59 | 217.47 | 25.72 | 28.05 | 29.90 | 55.23 | Upgrade
|
| PS Ratio | 5.38 | 6.48 | 6.10 | 5.64 | 5.01 | 3.83 | Upgrade
|
| PB Ratio | 2.45 | 2.53 | 3.24 | 3.56 | 3.01 | 2.24 | Upgrade
|
| P/TBV Ratio | 3.85 | 4.02 | 4.89 | 7.07 | 6.75 | 6.45 | Upgrade
|
| P/FCF Ratio | - | - | 57.87 | 17.76 | 25.77 | 30.41 | Upgrade
|
| P/OCF Ratio | 41.48 | - | 32.79 | 13.45 | 14.78 | 14.32 | Upgrade
|
| EV/Sales Ratio | 5.36 | 6.54 | 6.08 | 6.09 | 5.72 | 4.65 | Upgrade
|
| EV/EBITDA Ratio | 34.64 | 47.44 | 17.71 | 19.95 | 18.96 | 18.98 | Upgrade
|
| EV/EBIT Ratio | 71.71 | 147.80 | 21.18 | 24.76 | 24.44 | 28.27 | Upgrade
|
| EV/FCF Ratio | -1536.83 | - | 57.62 | 19.18 | 29.44 | 37.00 | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.29 | 0.15 | 0.60 | 0.53 | 0.97 | Upgrade
|
| Debt / EBITDA Ratio | 2.05 | 5.44 | 0.84 | 3.13 | 2.90 | 6.72 | Upgrade
|
| Debt / FCF Ratio | - | - | 2.72 | 3.01 | 4.50 | 13.10 | Upgrade
|
| Asset Turnover | 0.35 | 0.28 | 0.42 | 0.38 | 0.35 | 0.28 | Upgrade
|
| Inventory Turnover | 1.40 | 1.44 | 1.95 | 2.24 | 1.83 | 1.71 | Upgrade
|
| Quick Ratio | 1.22 | 1.13 | 1.76 | 0.80 | 1.01 | 0.82 | Upgrade
|
| Current Ratio | 2.02 | 1.60 | 2.37 | 1.02 | 1.43 | 1.06 | Upgrade
|
| Return on Equity (ROE) | 2.25% | 1.09% | 14.83% | 13.38% | 10.84% | 3.92% | Upgrade
|
| Return on Assets (ROA) | 1.63% | 0.77% | 7.56% | 5.91% | 5.13% | 2.88% | Upgrade
|
| Return on Capital (ROIC) | 1.75% | 0.83% | 8.38% | 6.53% | 5.48% | 3.06% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.30% | 1.70% | 15.00% | 15.20% | 11.30% | 7.60% | Upgrade
|
| Earnings Yield | 0.97% | 0.46% | 3.89% | 3.56% | 3.35% | 1.81% | Upgrade
|
| FCF Yield | -0.06% | -3.05% | 1.73% | 5.63% | 3.88% | 3.29% | Upgrade
|
| Dividend Yield | 0.57% | 0.56% | 2.89% | 3.06% | 4.24% | 6.35% | Upgrade
|
| Payout Ratio | 424.40% | 889.52% | 58.86% | 82.84% | 109.03% | 374.22% | Upgrade
|
| Buyback Yield / Dilution | -14.39% | -11.31% | -5.16% | -9.09% | -2.75% | 2.52% | Upgrade
|
| Total Shareholder Return | -13.81% | -10.75% | -2.27% | -6.03% | 1.49% | 8.87% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.